122 related articles for article (PubMed ID: 35818749)
21. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: a growing concern.
Malatack JF; Gartner JC; Urbach AH; Zitelli BJ
J Pediatr; 1991 May; 118(5):667-75. PubMed ID: 1850458
[TBL] [Abstract][Full Text] [Related]
22. Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate.
Kondo S; Tanimoto K; Yamada K; Yoshimoto G; Suematsu E; Fujisaki T; Oshiro Y; Tamura K; Takeshita M; Okamura S
Virchows Arch; 2013 Apr; 462(4):399-407. PubMed ID: 23494713
[TBL] [Abstract][Full Text] [Related]
23. Associated characteristics and impact on survival of post renal-transplantation lymphoproliferative disease: case-control study from a regional registry.
Gentil Govantes MA; Vidal Blandino M; Ruiz Esteban P; Rodelo Haad C; Torrado Masero J; Toro Ramos M; Burgos Rodríguez D; Alonso Gil M; Osuna Ortega A; Franco Esteve A
Transplant Proc; 2013; 45(10):3624-6. PubMed ID: 24314977
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders.
Takanashi S; Nakazato T; Aisa Y; Ito C; Arakaki H; Osada Y; Hirano M; Mori T
Ann Hematol; 2018 Sep; 97(9):1611-1618. PubMed ID: 29713747
[TBL] [Abstract][Full Text] [Related]
25. Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients.
Poullot E; Zambello R; Leblanc F; Bareau B; De March E; Roussel M; Boulland ML; Houot R; Renault A; Fest T; Semenzato G; Loughran T; Lamy T
Ann Oncol; 2014 Oct; 25(10):2030-2035. PubMed ID: 25096606
[TBL] [Abstract][Full Text] [Related]
26. [Lymphoproliferative lesions localized in the renal graft. A French multicenter study].
Renoult E; Kessler M
J Radiol; 1994 Jan; 75(1):53-6. PubMed ID: 8151542
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
[TBL] [Abstract][Full Text] [Related]
28. Value-based flow testing of chronic lymphoproliferative disorders: a quality improvement project to develop an algorithm to streamline testing and reduce costs.
Oberley MJ; Fitzgerald S; Yang DT; Morgan A; Johnson J; Leith C
Am J Clin Pathol; 2014 Sep; 142(3):411-8. PubMed ID: 25125633
[TBL] [Abstract][Full Text] [Related]
29. Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy.
Spillane AJ; Brennan ME
Eur J Surg Oncol; 2009 Apr; 35(4):380-6. PubMed ID: 18757165
[TBL] [Abstract][Full Text] [Related]
30. Polymorphous lymphoproliferative disorder: a clinicopathological analysis.
Nakamichi N; Wada N; Kohara M; Fukuhara S; Sugiyama H; Ogawa H; Hino M; Kanamaru A; Kanakura Y; Morii E; Aozasa K
Virchows Arch; 2010 Mar; 456(3):269-76. PubMed ID: 20111873
[TBL] [Abstract][Full Text] [Related]
31. Collision tumors with synchronous presentation of breast carcinoma and lymphoproliferative disorders in the axillary nodes of patients with newly diagnosed breast cancer: a case series.
Wahner-Roedler DL; Reynolds CA; Boughey JC
Clin Breast Cancer; 2011 Mar; 11(1):61-6. PubMed ID: 21421524
[TBL] [Abstract][Full Text] [Related]
32. The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders.
Tokuhira M; Tanaka Y; Takahashi Y; Kimura Y; Tomikawa T; Anan T; Watanabe J; Sagawa M; Higashi M; Momose S; Amano K; Tabayashi T; Nakaseko R; Tamaru JI; Kizaki M
J Clin Exp Hematop; 2020 Jun; 60(2):41-50. PubMed ID: 32404570
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
34. Refining the Limits of Borderline Lymphoproliferative Disorders.
Sorigue M; Raya M; Vergara S; Sarrate E; Orna E; Juncà J
Cytometry B Clin Cytom; 2019 Sep; 96(5):351-358. PubMed ID: 30592375
[TBL] [Abstract][Full Text] [Related]
35. Polymorphic lymphoproliferative disorders in patients with rheumatoid arthritis are associated with a better clinical outcome.
Tsukui D; Kanda H; Shinozaki-Ushiku A; Tateishi S; Takeshima Y; Nagafuchi Y; Sasaki O; Iwasaki Y; Harada H; Shibuya M; Sumitomo S; Shoda H; Kubo K; Fujio K; Nakamura F; Kurokawa M; Fukayama M; Yamamoto K
Mod Rheumatol; 2018 Jul; 28(4):621-625. PubMed ID: 29057700
[TBL] [Abstract][Full Text] [Related]
36. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
[TBL] [Abstract][Full Text] [Related]
37. Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract.
Perry AM; Bailey NG; Bonnett M; Jaffe ES; Chan WC
Int J Surg Pathol; 2019 Feb; 27(1):102-107. PubMed ID: 29986618
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and incidence of methotrexate-related lymphoproliferative disorders of patients with rheumatoid arthritis.
Yoshida Y; Takahashi Y; Yamashita H; Kano T; Kaneko H; Mimori A
Mod Rheumatol; 2014 Sep; 24(5):763-5. PubMed ID: 24498893
[TBL] [Abstract][Full Text] [Related]
39. Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature.
Nakanishi R; Ishida M; Hodohara K; Okuno H; Yoshii M; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2014; 7(4):1748-54. PubMed ID: 24817974
[TBL] [Abstract][Full Text] [Related]
40. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
